Medical News

RSS

Novavax reports positive preclinical results for H1N1 influenza VLP vaccine

Novavax, Inc. (Nasdaq: NVAX) announced positive preclinical results with Novavax's 2009 novel H1N1 influenza virus-like particle (VLP) vaccine. The study, conducted by scientists from Novavax and the Centers for Disease Control and Prevention (CDC) based in Atlanta, GA, under a collaborative agreement, represents the first efficacy report of a 2009 novel H1N1 vaccine in ferrets. The ferret model is widely accepted to be the most appropriate animal model for evaluating influenza disease and vaccines. Novavax scientists designed the vaccine using recombinant virus like particles (VLP) technology against an H1N1 virus strain (A/California/04/2009) isolated in the beginning of the 2009 H1N1 outbreak.

19 Aug 2009

Bioheart's executive management team strengthened by the inclusion of board members

Bioheart, Inc., (OTC Bulletin Board: BHRT) a company committed to delivering intelligent devices and biologics that help monitor, diagnose and treat heart failure and other cardiovascular diseases announced today that several of its Directors have joined the Company's executive management team. In addition to assuming the position of Chairman of the Company's Board of Directors, Karl E. Groth, Ph.D., became the Chief Executive Officer; Peggy A. Farley became Chief Operating Officer; and Mark P. Borman became Chief Financial Officer. Howard Leonhardt will continue as Chief Scientific and Technology Officer, and Chairman of the Scientific Advisory Board. Mr. Leonhardt, the Company's founder, thus will be able to focus on enhancing the Company's existing technologies and strengthening its position as the leader within the cardiovascular arena of the stem cell therapy industry.

19 Aug 2009

Orient Pharma granted commercialization rights for a drug candidate by DURECT

DURECT Corporation today announced that it has signed a development and license agreement with Orient Pharma Co., Ltd., a diversified multinational pharmaceutical, healthcare and consumer products company with headquarters in Taiwan, under which DURECT has granted to Orient Pharma development and commercialization rights in selected Asian and South Pacific countries to a drug candidate based on DURECT's ORADUR(R) Technology and one specified active pharmaceutical ingredient for the treatment of attention deficit hyperactivity disorder (ADHD).

19 Aug 2009

BioAlliance Pharma's new drug application for oropharyngeal candidiasis treatment accepted by the FDA

BioAlliance Pharma SA (Paris:BIO), a company dedicated to the treatment and supportive care of cancer and AIDS patients, today announced that the U.S. Food and Drug Administration (FDA) has accepted the new drug application (NDA) for miconazole Lauriad® (Loramyc®) Mucoadhesive Buccal Tablets (MBT) to treat oropharyngeal candidiasis (OPC). Miconazole Lauriad® delivers the antifungal miconazole via a mucoadhesive buccal tablet that is designed to enable once-daily dosing of the active ingredient at the site of infection.

19 Aug 2009

Research study highlights the biological importance of Vitamin D in humans and other primates

A new study has concluded that one key part of the immune system, the ability of vitamin D to regulate anti-bactericidal proteins, is so important that is has been conserved through almost 60 million years of evolution and is shared only by primates, including humans - but no other known animal species.

19 Aug 2009

Brain's motor and perception regions disconnected in tone-deaf people

Nerve fibers that link perception and motor regions of the brain are disconnected in tone-deaf people, according to new research in the August 19 issue of The Journal of Neuroscience. Experts estimate that at least 10 percent of the population may be tone deaf - unable to sing in tune. The new finding identifies a particular brain circuit that appears to be absent in these individuals.

19 Aug 2009

Solta Medical launches new Thermage Comfort Pulse Technology system

Solta Medical, Inc. (Nasdaq: SLTM) today announced the launch of its new Thermage CPT(TM) system, representing a significant leap forward in skin tightening and body contouring technology. The Thermage CPT system incorporates proprietary Comfort Pulse Technology(TM) in every aspect of the system including a new ergonomic vibrating hand piece and scientifically advanced Face Tip 3.0 and Body Tip 16.0 treatment tips.

19 Aug 2009

Hard to Treat Diseases' swine flu clinical trials in progress

Hard to Treat Diseases (HTDS.PK) Mellow Hope, an operating subsidiary of HTDS, is pleased to report that its clinical trial is currently being processed.

19 Aug 2009

Hospital Corporation of America appoints Bayard Advertising Agency as recruitment partner

Bayard Advertising Agency, Inc., an integrated branding and communications agency serving B2B and B2C clients in a broad array of industries, announces its selection as Recruitment Agency Of Record by Hospital Corporation of America (HCA) West Florida Division.

19 Aug 2009

Siemens Healthcare's SOMATOM Emotion 16 ranked highest among 16-slice CT systems

According to a recent report from market research firm KLAS*, Siemens Healthcare's SOMATOM(R) Emotion CT scanner is ranked highest among 16-slice CT systems. Powerful and cost-effective, the SOMATOM Emotion 16 enables facilities to not only perform routine examinations, such as brain, chest, and abdomen examinations, but also undertake high-end, detailed examinations, such as high-resolution CT angiography, which greatly improve patient care, as well as diagnostic workflow.

19 Aug 2009

CSL Biotherapies to supply Afluria influenza vaccines from newly licensed packaging facility

CSL Biotherapies, a subsidiary of CSL Limited, one of the world's leading manufacturers of influenza vaccine, announced today that the U.S. Food and Drug Administration (FDA) has licensed the company’s newest vaccine filling and packaging facility, located in Kankakee, Ill. The facility, part of an investment to expand CSL’s U.S. influenza vaccine production capabilities, includes a high-speed, single-dose vaccine syringe filling line.

19 Aug 2009

Researchers reveal new ways to detect the hidden biases of medical research

A study by researchers at the University of Leicester has revealed new ways to spot whether medical research has hidden biases. Writing in the prestigious British Medical Journal, Santiago Moreno and his colleagues demonstrate how to spot 'publication bias' in the reporting of clinical trials which potentially form the basis of Government and NHS health policies.

19 Aug 2009

Proposed health care reform legislation removes incentives for immigrants to learn English says McAlpin

"Proposed health care reform legislation now under consideration in Congress will add billions of dollars of un-reimbursed cost to the Medicare program to provide free interpreters for non-English speaking patients," says K.C. McAlpin, executive director of ProEnglish, a national organization that advocates for making English the official language of government in the United States.

19 Aug 2009

IVF treatment not to be combined with alternative therapies

Women who are desperately trying to get pregnant might want to avoid complementary and alternative medicine. The common belief is that it won't hurt to try alternative fertility treatments before reverting to in vitro fertilization (IVF). But a new study from Denmark finds that the success of IVF treatment is 30% lower among women who have used alternative medicine.

19 Aug 2009

US Spine awarded patent for Facet Fixation System

US Spine® announced today that it has been awarded the first patent in a series for its Facet Fixation System. The United States Patent and Trademark Office has assigned patent number 7,563,275 to the Facet Fixation System. US Spine began commercial launch of the system in 2008, which features the Facet Gun™ and Facet Bolt®.

19 Aug 2009

Brooks Rehabilitation's new specialty clinic to provide advanced treatments for back and neck

Brooks Rehabilitation's newest specialty clinic, the Brooks Center for Back & Neck Health, offers patients advanced treatments for both acute and chronic conditions of the spine, including whiplash, lumbar stenosis, cervical or lumbar radiculopathy, cervical or lumbar instability, sciatica, TMJ, osteoarthritis, degenerative disc disease, and more. According to the National Institutes of Health, back pain is the second most common reason Americans go to the doctor (headaches are the first), and among the most common reasons for surgery. Research has demonstrated the effectiveness of physical therapy for affecting outcomes in patients with spinal conditions.

19 Aug 2009

Young innovators Andrea Armani and Ellis Meng to feature in Technology Review magazine's 2009 TR35 list

The University of Southern California today announced that two faculty members from the USC Viterbi School of Engineering have been recognized by Technology Review magazine as some of the world's top innovators under the age of 35. Andrea Armani, Assistant Professor of Chemical Engineering and Materials Science, and Ellis Meng, Assistant Professor of Biomedical Engineering, will both appear on the prestigious 2009 TR35 list.

19 Aug 2009

MicroDynamics to introduce the MicroQC inspection microscope at Quality Expo

MicroDynamics will be introducing the MicroQC inspection microscope at Quality Expo. The MicroQC is a highly versatile, lightweight instrument that is extremely accurate with proven repeatable results.

19 Aug 2009

Compete rates Healthgrades.com number one doctor-ratings web site

HealthGrades.com is the #1 doctor-ratings Web site – by an enormous margin – according to an analysis of Web traffic by Compete, a TNS Media company. HealthGrades.com, long known for its hospital-quality ratings, is the public Web site of the leading healthcare ratings company, featuring quality reports and ratings of every practicing doctor, hospital and nursing home in the country.

19 Aug 2009

Joseph Finn announces inclusion of PRX-08066 therapeutics program in Phase 2 for respiratory indication

Joseph F. Finn, Jr., C.P.A. , announced today that the PRX-08066 Therapeutics Program in Phase 2 for respiratory indication will be part of the intellectual property offered for sale at the September 30, 2009 auction.

19 Aug 2009

Medical News

Novavax reports positive preclinical results for H1N1 influenza VLP vaccine

Bioheart's executive management team strengthened by the inclusion of board members

Orient Pharma granted commercialization rights for a drug candidate by DURECT

BioAlliance Pharma's new drug application for oropharyngeal candidiasis treatment accepted by the FDA

Research study highlights the biological importance of Vitamin D in humans and other primates

Brain's motor and perception regions disconnected in tone-deaf people

Solta Medical launches new Thermage Comfort Pulse Technology system

Hard to Treat Diseases' swine flu clinical trials in progress

Hospital Corporation of America appoints Bayard Advertising Agency as recruitment partner

Siemens Healthcare's SOMATOM Emotion 16 ranked highest among 16-slice CT systems

CSL Biotherapies to supply Afluria influenza vaccines from newly licensed packaging facility

Researchers reveal new ways to detect the hidden biases of medical research

Proposed health care reform legislation removes incentives for immigrants to learn English says McAlpin

IVF treatment not to be combined with alternative therapies

US Spine awarded patent for Facet Fixation System

Brooks Rehabilitation's new specialty clinic to provide advanced treatments for back and neck

Young innovators Andrea Armani and Ellis Meng to feature in Technology Review magazine's 2009 TR35 list

MicroDynamics to introduce the MicroQC inspection microscope at Quality Expo

Compete rates Healthgrades.com number one doctor-ratings web site

Joseph Finn announces inclusion of PRX-08066 therapeutics program in Phase 2 for respiratory indication

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Latest News